Phase II trial of preoperative bevacizumab (Bev), irinotecan (I), cisplatin (C), and radiation (RT) in esophageal adenocarcinoma: Preliminary safety analysis Meeting Abstract
| Authors: | Ilson, D.; Bains, M.; Rizk, N.; Rusch, V.; Flores, R.; Park, B.; Shah, M.; Kelsen, D.; Miron, B.; Goodman, K. |
| Abstract Title: | Phase II trial of preoperative bevacizumab (Bev), irinotecan (I), cisplatin (C), and radiation (RT) in esophageal adenocarcinoma: Preliminary safety analysis |
| Meeting Title: | 45th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 27 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2009 May 29-Jun 2 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2009-05-20 |
| Start Page: | 220s |
| Language: | English |
| ACCESSION: | WOS:000276606603163 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2009.27.15_suppl.4573 |
| Notes: | Meeting Abstract: 4573 -- Source: Wos |
